1. Home
  2. MDGL vs WTRG Comparison

MDGL vs WTRG Comparison

Compare MDGL & WTRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MDGL
  • WTRG
  • Stock Information
  • Founded
  • MDGL 2011
  • WTRG 1901
  • Country
  • MDGL United States
  • WTRG United States
  • Employees
  • MDGL N/A
  • WTRG N/A
  • Industry
  • MDGL Biotechnology: Pharmaceutical Preparations
  • WTRG Water Supply
  • Sector
  • MDGL Health Care
  • WTRG Utilities
  • Exchange
  • MDGL Nasdaq
  • WTRG Nasdaq
  • Market Cap
  • MDGL 9.6B
  • WTRG 10.9B
  • IPO Year
  • MDGL N/A
  • WTRG N/A
  • Fundamental
  • Price
  • MDGL $530.11
  • WTRG $39.09
  • Analyst Decision
  • MDGL Strong Buy
  • WTRG Buy
  • Analyst Count
  • MDGL 13
  • WTRG 7
  • Target Price
  • MDGL $523.92
  • WTRG $44.33
  • AVG Volume (30 Days)
  • MDGL 409.9K
  • WTRG 2.3M
  • Earning Date
  • MDGL 11-04-2025
  • WTRG 11-04-2025
  • Dividend Yield
  • MDGL N/A
  • WTRG 3.51%
  • EPS Growth
  • MDGL N/A
  • WTRG 20.57
  • EPS
  • MDGL N/A
  • WTRG 2.40
  • Revenue
  • MDGL $740,640,000.00
  • WTRG $2,379,887,000.00
  • Revenue This Year
  • MDGL $395.75
  • WTRG $13.46
  • Revenue Next Year
  • MDGL $65.73
  • WTRG $5.45
  • P/E Ratio
  • MDGL N/A
  • WTRG $16.29
  • Revenue Growth
  • MDGL 864.21
  • WTRG 21.35
  • 52 Week Low
  • MDGL $265.00
  • WTRG $33.18
  • 52 Week High
  • MDGL $544.25
  • WTRG $42.37
  • Technical
  • Relative Strength Index (RSI)
  • MDGL 74.00
  • WTRG 45.18
  • Support Level
  • MDGL $399.00
  • WTRG $39.02
  • Resistance Level
  • MDGL $544.25
  • WTRG $39.73
  • Average True Range (ATR)
  • MDGL 27.05
  • WTRG 0.86
  • MACD
  • MDGL 11.07
  • WTRG -0.13
  • Stochastic Oscillator
  • MDGL 91.20
  • WTRG 31.67

About MDGL Madrigal Pharmaceuticals Inc.

Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, and premature mortality. The company's medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor agonist designed to target key underlying causes of MASH.

About WTRG Essential Utilities Inc.

Essential Utilities is a Pennsylvania-based holding company for US water, wastewater, and natural gas distribution utilities. The company's water business serves 3 million people in eight states. Its largest service territory is in Pennsylvania, primarily suburban Philadelphia. Its Peoples subsidiary serves more than 740,000 gas distribution customers in Pennsylvania and Kentucky. It completed the sale of its West Virginia gas utility and the bulk of its nonregulated assets in 2024. Essential shareholders would own a 31% stake in American Water Works if the proposed all-stock merger closes in 2027.

Share on Social Networks: